Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT04430426

Heterozygous Individuals for AGXT and Kidney Stones

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
4 (estimated)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study seeks to examine the effects of a heterozygous mutation of the AGXT gene in a stone forming population on endogenous oxalate production. Participants will consume a controlled low-oxalate diet and provide blood and urine samples to measure the amount of oxalate in their bodies. Subjects will then be administered an intravenous (IV) load of glycolate, providing additional blood and urine samples afterwards to measure any increase in oxalate levels.

Conditions

Interventions

TypeNameDescription
OTHERControlled DietParticipants will consume a controlled low oxalate diet for five days.
OTHERGlycolate AdministrationParticipants will come to the UAB Clinical Research Unit (CRU) and be administered a glycolate load via intravenous (IV) catheter.

Timeline

Start date
2026-07-01
Primary completion
2031-08-01
Completion
2032-08-01
First posted
2020-06-12
Last updated
2025-07-04

Source: ClinicalTrials.gov record NCT04430426. Inclusion in this directory is not an endorsement.